Brazil case 242k. plus 1.2k.

demand is still there and growing more and more.

careglove will benefit from it.

before pandemic , careplus earned 50% with Brazilian co. which resulted 15m profit (approx)

now careplus already acquired 100% of careglove.

your guess?

my guess is at least 40m for profit (increased usage of glove due to pandemic)

not including price surge.

don't worry just be happy ....
relax relax.. enjoy the ride..

first qtr will be marvelous. 2nd qtr will be epic !

just hold tight. whatever rebound just avg down.

if I don't trust this company I will sold and let go at 1.15

but I STRONGLY believe will be 1.5 and above.


don't worry. uninstall and move on with your life. don't need to keep seeing my nudging comment hahaha

that's CMSB. another sub company of c+ which is bad in management and high debt.

SOLD to Ansell!

money gained is to offset debt (25m) and another 10m is to expend with Ansell.


what is your view for Aussie 25 dollars listed company to uplift 80sen MYR company??

Ansell one blow careplus also can rm2 la.....

CMSB , the lost making unit under careplus is now money making cow for careplus (Europe) market.

hold. even 40 sen , 30 sen, 20 sen or 10 sen. I won't cut lost.
why kill my money cow?

count CMSB out. eps should be 2.3

estimated Brazil demand and fully owned careglove. eps fy2020 8sen

at pe 10 entry price 89-95

at pe 15 entry price 1.2

how about avg glove sector at pe30 ?

that's why I say 1.5 is a safe bet and possible and achievable value.

but I'll plan to hold some of careplus share for long term. who knows it is top glove to be in 20 years time ahead?!

nothing is impossible.

again that's all assumption and estimation . just a better guidance for us out there

yup. 50 50. at fist they agree on 25m but up 10m because of share price surge and market demand surge. it is very kind of Ansell still accept that offer.

I entered during that time. a bit of gamble but that is the best offer I can get.

if ansell rejects, i am looking at 20cents c+ now.


power of aus listed company.. hahaha

Careplus (Current price 90 Sen - Buy on Weakness and Price Volume Movement)

The estimated Qtr EPS could be range from 2.05 Sen to 2.3 Sen. The estimated FY 2020 EPS could range from 8.2 Sen to 9.2 Sen.

At PE 12, ITS VALUATION COULD RANGE FROM 98.4 TO 110.
At PE 15, VALUATION COULD RANGGE FROM 123 TO 138

Consider to enter at 85 Sen

New Catalysts for higher upside of share price

• Completion of disposal of 50% equity interest in Careplus (M) S/B (CMSB), a wholly owned subsidiary to Ansell f